BMRB Entry 6980

Name: Chemical Shift Assignment of human allograft inflammatory factor I
Published: 2006-03-29

Click here to enlarge.

PDB ID: 2g2b
Entry in NMR Restraints Grid
Validation report in NRG-CING
Chem Shift validation: AVS_full, LACS, SPARTA
BMRB Entry DOI: doi:10.13018/BMR6980
MolProbity Validation Chart

NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
XML gzip file.
RDF gzip file.
All files associated with the entry

Nicholas Rego and David Koes
3Dmol.js: molecular visualization with WebGL
Bioinformatics (2015) 31 (8): 1322-1324 doi:10.1093/bioinformatics/btu829

Select model:

I am color blind

Download raw data. Direct link to this display. Help

Title:

Chemical Shift Assignment of human allograft inflammatory factor I

Deposition date:

2006-02-13

Original release date:

2006-03-29

Authors:

Song, Jikui; Tyler, Robert; Loushin Newman, Carrie; Vinarov, Dmitriy; Markley, John

Citation:

Citation: Song, Jikui; Tyler, Robert; Loushin Newman, Carrie; Vinarov, Dmitriy; Markley, John. "Solution Structure of Human Allograft Inflammatory Factor I" .

Assembly members:

Assembly members:
Allograft inflammatory factor 1, polymer, 150 residues, Formula weight is not available
CA, non-polymer, 40.078 Da.

Natural source:

Natural source: Common Name: Human Taxonomy ID: 9606 Superkingdom: Eukaryota Kingdom: Metazoa Genus/species: Homo sapiens

Experimental source:

Experimental source: Production method: cell free synthesis

Entity Sequences (FASTA):

Entity Sequences (FASTA):
Allograft inflammatory factor 1: GPLESQTRDLQGGKAFGLLK AQQEERLDEINKQFLDDPKY SSDEDLPSKLEGFKEKYMEF DLNGNGDIDIMSLKRMLEKL GVPKTHLELKKLIGEVSSGS GETFSYPDFLRMMLGKRSAI LKMILMYEEKAREKEKPTGP PAKKAISELP

Data sets:

assigned_chemical_shifts
- chem_shift_list_1

Data type	Count
13C chemical shifts	591
15N chemical shifts	144
1H chemical shifts	860

Time Domain Data

Additional metadata:

Assembly
Samples and Experiments
Software
Spectrometers
Hide all

Assembly:

Entity Assembly ID	Entity Name	Entity ID
1	BC009474	1
2	CALCIUM (II) ION	2

Entities:

Entity 1, BC009474 150 residues - Formula weight is not available

1	GLY	PRO	LEU	GLU	SER	GLN	THR	ARG	ASP	LEU
2	GLN	GLY	GLY	LYS	ALA	PHE	GLY	LEU	LEU	LYS
3	ALA	GLN	GLN	GLU	GLU	ARG	LEU	ASP	GLU	ILE
4	ASN	LYS	GLN	PHE	LEU	ASP	ASP	PRO	LYS	TYR
5	SER	SER	ASP	GLU	ASP	LEU	PRO	SER	LYS	LEU
6	GLU	GLY	PHE	LYS	GLU	LYS	TYR	MET	GLU	PHE
7	ASP	LEU	ASN	GLY	ASN	GLY	ASP	ILE	ASP	ILE
8	MET	SER	LEU	LYS	ARG	MET	LEU	GLU	LYS	LEU
9	GLY	VAL	PRO	LYS	THR	HIS	LEU	GLU	LEU	LYS
10	LYS	LEU	ILE	GLY	GLU	VAL	SER	SER	GLY	SER
11	GLY	GLU	THR	PHE	SER	TYR	PRO	ASP	PHE	LEU
12	ARG	MET	MET	LEU	GLY	LYS	ARG	SER	ALA	ILE
13	LEU	LYS	MET	ILE	LEU	MET	TYR	GLU	GLU	LYS
14	ALA	ARG	GLU	LYS	GLU	LYS	PRO	THR	GLY	PRO
15	PRO	ALA	LYS	LYS	ALA	ILE	SER	GLU	LEU	PRO

Entity 2, CALCIUM (II) ION - Ca - 40.078 Da.

1

CA

Samples:

sample_1: Allograft inflammatory factor 1 0.5 ± 0.1 mM; MOPS 10 ± 1 mM; NaCl 100 ± 5 mM

conditions_1: ionic strength: 100 mM; pH: 7.0; pressure: 1 atm; temperature: 298 K

Experiments:

Name	Sample	Sample state	Sample conditions
1H,15N-HSQC	sample_1	not available	conditions_1
1H,13C-HSQC	sample_1	not available	conditions_1
HNCACB	sample_1	not available	conditions_1
CBCACONH	sample_1	not available	conditions_1
HCCHTOCSY	sample_1	not available	conditions_1
CCONH	sample_1	not available	conditions_1
HCCONH	sample_1	not available	conditions_1
3D C13NOESY	sample_1	not available	conditions_1
3D N15NOESY	sample_1	not available	conditions_1
HBACONH	sample_1	not available	conditions_1
HBCBCGCDHD	sample_1	not available	conditions_1
HBCBCGCDCEHE	sample_1	not available	conditions_1

Software:

No software information available

NMR spectrometers:

Varian Inova 600 MHz
Bruker DMX 500 MHz
Bruker DMX 750 MHz

PDB	2D58 2G2B
DBJ	BAA13088 BAB63392 BAD69720 BAF83460
EMBL	CAA75060 CAA75062 CAG46950
GB	AAB05003 AAD18087 AAF98708 AAG39110 AAH09474
REF	NP_001040583 NP_001614 NP_116573 XP_001154743 XP_002816779
SP	P55008 Q5TM25
AlphaFold	P55008 Q5TM25

1	GLY	PRO	LEU	GLU	SER	GLN	THR	ARG	ASP	LEU
2	GLN	GLY	GLY	LYS	ALA	PHE	GLY	LEU	LEU	LYS
3	ALA	GLN	GLN	GLU	GLU	ARG	LEU	ASP	GLU	ILE
4	ASN	LYS	GLN	PHE	LEU	ASP	ASP	PRO	LYS	TYR
5	SER	SER	ASP	GLU	ASP	LEU	PRO	SER	LYS	LEU
6	GLU	GLY	PHE	LYS	GLU	LYS	TYR	MET	GLU	PHE
7	ASP	LEU	ASN	GLY	ASN	GLY	ASP	ILE	ASP	ILE
8	MET	SER	LEU	LYS	ARG	MET	LEU	GLU	LYS	LEU
9	GLY	VAL	PRO	LYS	THR	HIS	LEU	GLU	LEU	LYS
10	LYS	LEU	ILE	GLY	GLU	VAL	SER	SER	GLY	SER
11	GLY	GLU	THR	PHE	SER	TYR	PRO	ASP	PHE	LEU
12	ARG	MET	MET	LEU	GLY	LYS	ARG	SER	ALA	ILE
13	LEU	LYS	MET	ILE	LEU	MET	TYR	GLU	GLU	LYS
14	ALA	ARG	GLU	LYS	GLU	LYS	PRO	THR	GLY	PRO
15	PRO	ALA	LYS	LYS	ALA	ILE	SER	GLU	LEU	PRO

1	GLY	PRO	LEU	GLU	SER	GLN	THR	ARG	ASP	LEU
2	GLN	GLY	GLY	LYS	ALA	PHE	GLY	LEU	LEU	LYS
3	ALA	GLN	GLN	GLU	GLU	ARG	LEU	ASP	GLU	ILE
4	ASN	LYS	GLN	PHE	LEU	ASP	ASP	PRO	LYS	TYR
5	SER	SER	ASP	GLU	ASP	LEU	PRO	SER	LYS	LEU
6	GLU	GLY	PHE	LYS	GLU	LYS	TYR	MET	GLU	PHE
7	ASP	LEU	ASN	GLY	ASN	GLY	ASP	ILE	ASP	ILE
8	MET	SER	LEU	LYS	ARG	MET	LEU	GLU	LYS	LEU
9	GLY	VAL	PRO	LYS	THR	HIS	LEU	GLU	LEU	LYS
10	LYS	LEU	ILE	GLY	GLU	VAL	SER	SER	GLY	SER
11	GLY	GLU	THR	PHE	SER	TYR	PRO	ASP	PHE	LEU
12	ARG	MET	MET	LEU	GLY	LYS	ARG	SER	ALA	ILE
13	LEU	LYS	MET	ILE	LEU	MET	TYR	GLU	GLU	LYS
14	ALA	ARG	GLU	LYS	GLU	LYS	PRO	THR	GLY	PRO
15	PRO	ALA	LYS	LYS	ALA	ILE	SER	GLU	LEU	PRO